NASDAQ:ICCC
ImmuCell Corporation Stock News
$4.91
-0.190 (-3.73%)
At Close: Apr 30, 2024
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
04:05pm, Thursday, 12'th Aug 2021
Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000) Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000)
ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
06:30am, Thursday, 05'th Aug 2021
Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2021 Results - Earnings Call Transcript
11:52am, Friday, 14'th May 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2021 Results - Earnings Call Transcript
ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021
01:41pm, Thursday, 06'th May 2021
Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET
ImmuCell Closes $4,250,000 Equity Financing
05:15pm, Wednesday, 14'th Apr 2021
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021
08:00am, Wednesday, 07'th Apr 2021
PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2020 Results - Earnings Call Transcript
10:17am, Tuesday, 23'rd Feb 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2020 Results - Earnings Call Transcript
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020
01:42pm, Tuesday, 16'th Feb 2021
Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET
ImmuCell Announces Restructuring of its Bank Debt
04:05pm, Tuesday, 15'th Dec 2020
PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q3 2020 Results - Earnings Call Transcript
01:43pm, Friday, 13'th Nov 2020
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q3 2020 Results - Earnings Call Transcript
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020
02:10pm, Thursday, 05'th Nov 2020
Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ET Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ET
ImmuCell Corporation 2020 Q2 - Results - Earnings Call Presentation
03:41pm, Thursday, 13'th Aug 2020
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q2 earnings call.
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2020 Results - Earnings Call Transcript
01:25pm, Thursday, 13'th Aug 2020
ImmuCell Corporation (NASDAQ:ICCC) Q2 2020 Results Earnings Conference Call August 13, 2020, 9:00 am ET Company Participants Michael Brigham - President, Chief Executive Officer, Director Joe Diaz - I
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020
08:05pm, Wednesday, 12'th Aug 2020
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
Reviewing ImmuCell (ICCC) & The Competition
04:44am, Sunday, 09'th Aug 2020
ImmuCell (NASDAQ: ICCC) is one of 25 public companies in the “Diagnostic substances” industry, but how does it contrast to its peers? We will compare ImmuCell to related companies based on the str
